cdmo.directory
← Compare landing

Catalent vs Charles River Cell & Gene Therapy

Auto-generated comparison by BioBM Editorial AI. This page highlights available profile evidence side by side and avoids drawing conclusions from missing fields.

Markdown mirror: /api/markdown/compare/catalent/criver

CategoryCatalentCharles River Cell & Gene Therapy
Listed sitecdmocdmo
SummaryLeading global CDMO offering end-to-end development and manufacturing for pharma, biotech, and consumer health—spanning oral dose, biologics, cell and gene therapies, clinical supply, and specialty formulations with advanced technologies and worldwide GMP capacity.Charles River provides discovery, development, and manufacturing services across the drug development continuum, including cell and gene therapy capabilities.
Services
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • AAV Manufacturing
  • Oral Solid Dosage Manufacturing
  • Inhalation & Nasal Dosage Manufacturing
  • Formulation Development
  • Process Development
  • CMC Analytical Development
  • Technology Transfer
  • Sterile Fill-Finish & Aseptic Manufacturing
  • Quality Control Testing
  • Recombinant Protein Manufacturing
  • Biologics Development & Manufacturing
  • API Synthesis & Manufacturing
  • Small Molecule Development & Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Secondary Packaging & Labeling
  • Stability Testing & Storage
  • CMC Regulatory Submission Support
  • Cell-Line Development
  • Upstream Processing
  • Downstream Processing
  • Vial Filling
  • Prefilled Syringe (PFS) Filling
  • Topical & Semi-Solid Manufacturing
  • Serialization & Track-and-Trace
  • Cold-Chain Storage & Logistics
  • Cartridge Filling
  • Lyophilization (Freeze Drying)
  • Lentiviral Vector Manufacturing
  • CMC Regulatory Submission Support
  • Quality Control Testing
  • Technology Transfer
  • Formulation Development
  • Process Development
  • Cell Therapy Manufacturing
  • Viral Vector Manufacturing
  • Recombinant Protein Manufacturing
  • Monoclonal Antibody (mAb) Manufacturing
  • Biologics Development & Manufacturing
  • API Synthesis & Manufacturing
  • Upstream Processing
  • Downstream Processing
  • CMC Analytical Development
  • Stability Testing & Storage
  • Cell-Line Development
  • Microbial Fermentation
  • Small Molecule Development & Manufacturing
  • AAV Manufacturing
  • Lentiviral Vector Manufacturing
  • Sterile Fill-Finish & Aseptic Manufacturing
Modalities
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
  • Small Molecule
  • Biologics (Monoclonal Antibodies)
  • Biologics (Other)
  • Cell Therapy
  • Gene Therapy
  • AAV / Viral Vector Platform
IndicationsData not yet provided.
  • Oncology
  • Immunology
  • Neurology
Locations
  • Headquarters, United States
  • Asia Pacific, Asia Pacific
  • Europe, Europe
  • Latin America, Latin America
  • North America, North America, United States
  • China, China
  • Japan, Japan
  • North America, North America
  • Global Network
  • Headquarters, United States
  • North America, North America
  • Europe, Europe
  • Asia, Asia
Certifications
  • GMP · Identifier: Nine GMP facilities
  • FDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • PMDA · Identifier: 100 IND submissions containing Retrogenix® platform data
  • EMA · Identifier: Retrogenix® platform data support
  • PMDA · Identifier: Retrogenix® platform data support
ReviewsReview summary appears after site-level review signal gate opens.Review summary appears after site-level review signal gate opens.